Brigitte Linseis - Profile and Investment Details

Investor Profile

Brigitte Linseis is a Venture Capital, Government Office, Private Equity Firm, Investor based in Landshut, Bavaria, Germany with a diverse investment portfolio that includes companies such as Ondeso, Mecuris, SimScale, Veact, parcelLab, casavi, reINVENT, GME Medical Engineering, Testbirds, Cobrainer GmbH, Leadtributor, Vasopharm, MicroStream, Cevotec, Fineway, Holo-Light, All3DP GmbHExB Labs, Riskmethods, Delicious Data, Tubulis, metoda, Cunesoft GmbH, iThera Medical, Scompler, Libify, Theva, Reactive Robotics, medineering, numares HEALTH, Bilendo, ProGlove, microDimensions, TerraLoupe, TriOptoTec, EGYM, Photonics Healthcare, Gastfreund, Mietercasting, Lophius Biosciences, advanceCOR, NeoPrediX, Shore, Conntac, iATROS, Easy-Tutor GmbH, fos4X, Daypaio, Evum Motors, FAZUA, Immunic, Multiphoton Optics GmbH, Coredinate, Seiratherm, Arzneimittelwerk Warngau, adnymics, wealthpilot, Whiteout Networks, Thermosome, Crealytics, BlueID GmbH, apaleo, VoltStorage, . Over time, Brigitte Linseis has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Brigitte Linseis is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Wearables, Sports, Wellness, Education, Artificial Intelligence (AI), Small and Medium Businesses, Robotics, Information Technology (IT), Analytics, Software, Biotechnology, Electronic Health Records (EHR), Health and Hospital Services, Food and Beverage, FinTech, Travel, Medical, SaaS may find it worthwhile to explore potential connections with Brigitte Linseis, as their portfolio suggests a familiarity and interest in this area.

Understanding Brigitte Linseis’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.